Clin2
NCT07777549Possibly a fitNot yet recruiting

Study of TRTL-913 for tinnitus

Tinnitus

Part of Brain & nervous system, Ear, nose & throat clinical trials.

This study tests a new drug called TRTL-913 to see if it is safe and helps reduce tinnitus (ringing in the ears). It has two parts: one for healthy volunteers and one for people with tinnitus.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 2
Enrollment
100 people
Ages
18 years to 80 years
Study type
Interventional

Who can take part

  • You are between 18 and 64 years old.
  • You have had stable, non-pulsatile tinnitus for a while (not caused by blood flow).
  • You are generally healthy aside from tinnitus.
  • Your body mass index (BMI) is between 18 and 35.
  • You agree to stop other tinnitus treatments during the study.
  • You are willing to use effective birth control if you could become pregnant.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT03511807Recruiting
Tests sound and mild electrical stimulation for tinnitus relief

This study tests whether adding sound and/or mild electrical stimulation can reduce tinnitus (ringing or other noises in the ear). It is looking for adults who have had tinnitus for at least 6 months and can complete questionnaires about what they feel.

Irvine, California
NCT07393880Recruiting
Sound and training for chronic tinnitus

This trial combines sound therapy with electrical stimulation and auditory training to reduce chronic tonal tinnitus. It may help if you have had constant ringing in your ears for more than 3 months but less than 5 years.

Dublin, Dublin
NCT06641999Recruiting
Tinnitus implant study for adults with chronic tinnitus and hearing loss

This trial tests if a special implant can reduce tinnitus loudness in adults who have had chronic tinnitus for at least 6 months and have some hearing loss. You may qualify if your tinnitus is severe and not helped by standard treatments like hearing aids or therapy.

Edegem, Belgium
NCT04192773Recruiting· Early Phase 1
Brain-scan study of IV lidocaine for tinnitus

This early study uses an MRI/brain scan to see how IV lidocaine affects brain activity in people with tinnitus, and also compares it with people without tinnitus or with different hearing patterns. It may help researchers understand whether lidocaine could change tinnitus signals in the brain.

Boston, Massachusetts
NCT07298499Enrolling by invitation
Hearing aids and sound therapy for tinnitus

This trial tests using hearing aids with built-in tinnitus maskers to see if they help adults who have both hearing loss and ringing in the ears. It aims to find out if these devices improve hearing and reduce tinnitus symptoms.

Broomfield, Colorado
NCT07648615Not yet recruiting
Testing a tinnitus implant for severe ringing in ears

This trial tests a small implant designed to reduce severe tinnitus (constant ringing in the ears) in one ear without damaging your hearing. You may qualify if you've had severe tinnitus for at least a year, haven't been helped by hearing aids or other treatments, and are willing to undergo surgery.

Hear when a new Tinnitus trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.